Lars Toleikis

Title: Innovations of Lars Toleikis

Introduction

Lars Toleikis is a notable inventor based in Kleinniedesheim, Germany. He has made significant contributions to the field of immunology, particularly through his innovative patents. With a total of seven patents to his name, Toleikis has focused on developing immunoglobulins that target specific proteins involved in various biological processes.

Latest Patents

One of his latest patents involves MMP13 binding immunoglobulins. This invention relates to immunoglobulins that specifically bind MMP13, including polypeptides and nucleic acids encoding such polypeptides. The invention also covers methods for preparing these polypeptides and pharmaceutical compositions that include them for therapeutic, prophylactic, or diagnostic purposes. Another significant patent focuses on polypeptides that bind ADAMTS5, MMP13, and aggrecan. This invention includes constructs comprising immunoglobulins that bind these proteins, along with methods for their preparation and applications in therapeutic contexts.

Career Highlights

Throughout his career, Lars Toleikis has worked with prominent companies in the pharmaceutical and biotechnology sectors. Notably, he has been associated with Merck Patent GmbH and Ablynx N.V. His work in these organizations has contributed to advancements in drug development and therapeutic solutions.

Collaborations

Lars Toleikis has collaborated with esteemed colleagues such as Gerald Beste and Christoph Hubertus Ladel. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.

Conclusion

Lars Toleikis is a distinguished inventor whose work in immunology has led to several impactful patents. His contributions continue to influence the field and hold promise for future therapeutic applications.